Skip to main content
Novartis AG logo

Novartis AG — Investor Relations & Filings

Ticker · NOVN ISIN · CH0038459415 LEI · 5493007HIVTX6SY6XD66 SW Manufacturing
Open in API
Filings indexed 1,070 across all filing types
Latest filing 2023-09-05 Regulatory Filings
Country CH Switzerland
Listing SW NOVN

About Novartis AG

https://www.novartis.com/

Novartis AG is a global medicines company focused on the research, development, manufacturing, and marketing of innovative healthcare products. The company's mission is to reimagine medicine to improve and extend people's lives. By leveraging advanced science and technology, Novartis develops a portfolio of treatments across various therapeutic areas to address the evolving needs of patients and societies. The firm is committed to delivering high-value medicines that tackle some of the most challenging healthcare issues worldwide.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings
2023-09-05 English
FORM 6-K
Regulatory Filings
2023-08-21 English
FORM 6-K
Regulatory Filings
2023-08-09 English
Obvestilo o spremembi pomembnega deleža družbe Sandoz AG
Major Shareholding Notification Classification · 99% confidence The document is titled "OBRAZEC ZA OBVEŠČANJE O SPREMEMBI POMEMBNIH DELEŽEV" (Form for Notification of Change in Significant Holdings) and explicitly details the acquisition of voting rights/shares (100% stake) by Sandoz AG in Lek farmacevtska družba d.d. on July 27, 2023. This type of filing, concerning changes in significant share ownership thresholds, directly corresponds to the definition of a Major Shareholding Notification. The Slovenian title and structure align with regulatory requirements for notifying changes in major shareholdings.
2023-08-07 Slovene
Obvestilo o spremembi pomembnega deleža družbe Novartis Pharma AG
Major Shareholding Notification Classification · 99% confidence The document is titled "OBRAZEC ZA OBVEŠČANJE O SPREMEMBI POMEMBNIH DELEŽEV" (Form for Notification of Change in Significant Holdings) and explicitly details the acquisition or disposal of voting rights (Točka 2: Pridobitev ali odsvojitev glasovalnih pravic). It specifies the parties involved (Lek farmacevtska družba d.d., Novartis Pharma AG, Sandoz AG), the transaction date (27. 7. 2023), and the resulting change in shareholding percentage (ending at 0%). This structure and content perfectly match the requirements for a Major Shareholding Notification, which in the provided list corresponds to code MRQ.
2023-08-07 Slovene
Obvestilo o spremembi pomembnega deleža
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled "Obvestilo o spremembi pomembnega deleža" (Notification of Change in Significant Shareholding) and references Slovenian financial instrument law (ZTFI-1) regarding significant shareholdings. The content details the transfer of a large block of shares (100.00% of voting rights) between Novartis Pharma AG and Sandoz AG. This directly corresponds to the definition of a Major Shareholding Notification.
2023-08-07 Slovene

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.